Trevena's Series A Round

Trevena raised a round of funding on March 24, 2008.

Trevena is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G protein coupled receptor (GPCR) targeted medicines. Despite the past success of GPCR d…

Articles about Trevena's Series A Round: